Biodesix Inc Liquidation Value

BDSX Other

Cash & Equivalents

$18.99M
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $18.99M
Total Obligations: -$92.84M
$-73.86M
Per share: $-8.95
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $18.99M
AR: $9.04M
Total Obligations: -$92.84M
$-64.82M
Per share: $-7.85
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $18.99M
AR: $9.04M
Inventory: $49,000
Total Obligations: -$92.84M
$-64.77M
Per share: $-7.85
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-73.86M$-8.95
Liquid Liquidation Value$-64.82M$-7.85
Operating Liquidation Value$-64.77M$-7.85

Key Components (as of 2025-12-31)

Cash & Equivalents$18.99M
Accounts Receivable$9.04M
Inventory$49,000
Current Liabilities$17.44M
Long-term Debt$50.01M
Op. Lease Liability$25.40M
Finance LeaseN/A
Shares Outstanding8.3M

Explore all 169 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$18.99M$9.04M$49,000$3.08M$17.44M$50.01M$25.40MN/A
2025-09-30$16.60M$12.67M$21,000$3.62M$18.15M$50.01M$25.81MN/A
2025-06-30$20.73M$7.45M$11,000$2.97M$15.16M$50.02M$25.34MN/A
2025-03-31$17.60M$7.64MN/A$2.92M$13.32M$40.02M$25.57MN/A
2024-12-31$26.25M$8.60M$22,000$2.19M$14.32M$40.03M$25.55MN/A
2024-09-30$31.41M$8.04M$20,000$2.54M$12.96M$40.04M$25.82MN/A
2024-06-30$42.22M$10.13M$12,000$2.22M$17.55M$40.05M$25.78MN/A
2024-03-31$11.49M$9.89M$8,000$3.21M$31.23M$40.06M$25.62MN/A

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-02-26 View
2025-09-30 10-Q 2025-11-03 View
2025-06-30 10-Q 2025-08-07 View
2025-03-31 10-Q 2025-05-13 View
2024-12-31 10-K 2025-03-03 View
2024-09-30 10-Q 2024-11-01 View
2024-06-30 10-Q 2024-08-07 View
2024-03-31 10-Q 2024-05-08 View

Community Notes

Loading notes...

Questions

Loading questions...